SURA'A Campaign for Stroke Awareness in Primary Health Centers

NCT07578259 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2026-05-13

No results posted yet for this study

Summary

This study aims to evaluate the effectiveness of a one-week multifaceted Stroke Urgency Recognition, and Action Awareness (SURA'A) consultation-based campaign in increasing stroke awareness and the intention to seek emergency medical help among adults. The research will be conducted at primary health care centers to determine if this specific educational approach can improve the community's response to stroke symptoms.

Conditions

Interventions

BEHAVIORAL

SURA'A Consultation-Based Campaign

The intervention consists of a one-week multifaceted SURA'A consultation-based campaign. This campaign is designed to increase stroke awareness and the intention to seek help among adults attending Primary Health Care Centers. The multifaceted approach likely includes: Targeted Consultations: Providing direct information to participants regarding stroke symptoms and emergency protocols. Educational Outreach: Utilizing the SURA'A framework-which typically focuses on rapid response (Sura'a meaning "speed" in Arabic)-to emphasize the importance of time-sensitive medical intervention. Community Integration: Implementing the campaign within the primary care setting to reach a diverse adult population during their routine health visits.

Sponsors & Collaborators

  • University of Baghdad

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-10
Primary Completion
2027-01-20
Completion
2027-04-10

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07578259 on ClinicalTrials.gov